HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 216 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,877,000 | -3.7% | 150,220 | 0.0% | 0.58% | -16.3% |
| Q2 2020 | $4,027,000 | +49.0% | 150,220 | 0.0% | 0.70% | +31.2% |
| Q1 2020 | $2,702,000 | +1.6% | 150,220 | +0.1% | 0.53% | +15.2% |
| Q4 2019 | $2,660,000 | -27.5% | 150,000 | -36.6% | 0.46% | -34.1% |
| Q3 2019 | $3,669,000 | -9.7% | 236,540 | 0.0% | 0.70% | -11.0% |
| Q2 2019 | $4,064,000 | +6.7% | 236,540 | 0.0% | 0.79% | -0.8% |
| Q1 2019 | $3,808,000 | +10.0% | 236,540 | 0.0% | 0.79% | -5.6% |
| Q4 2018 | $3,461,000 | – | 236,540 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |